
This content was machine translated.
About MediOwl
I’m Camila, not only CEO of MediOwl, but also a rheumatology patient. Worldwide, 420 million people suffer from various inflammatory diseases, but we all share the same problem: uncertainty. This is overwhelming and leaves you feeling powerless. At MediOwl, we develop monitoring devices for patients with chronic inflammation. Our all-in-one solution provides doctors with insights to better monitor their patients, and enables patients to effectively manage their condition. At MediOwl, we don’t just offer patients devices; we offer them a toolkit to regain control of their lives. If you know rheumatologists interested in our study, tell them about our Owl Eyes and our mission to see patients thrive.
More like this
